Insulin-like growth factors and liver cancer risk in male smokers

[1]  D. Albanes,et al.  Insulin-like growth factors and risk of kidney cancer in men , 2010, British Journal of Cancer.

[2]  M. Kuusi,et al.  Infectious diseases in Finland 1995-2009 , 2010 .

[3]  Ross J. Harris,et al.  Circulating insulin‐like growth factor peptides and prostate cancer risk: A systematic review and meta‐analysis , 2009, International journal of cancer.

[4]  D. Albanes,et al.  Glioma Risk in Relation to Serum Levels of Insulin-Like Growth Factors , 2007, Cancer Epidemiology Biomarkers & Prevention.

[5]  D. Yee,et al.  Disrupting insulin-like growth factor signaling as a potential cancer therapy , 2007, Molecular Cancer Therapeutics.

[6]  J. Pavelić,et al.  Biological & physiological aspects of action of insulin-like growth factor peptide family. , 2007, The Indian journal of medical research.

[7]  Colin W Shepard,et al.  Hepatitis B virus infection: epidemiology and vaccination. , 2006, Epidemiologic reviews.

[8]  Mohamed Yousry Elsammak,et al.  Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis. , 2006, Clinical biochemistry.

[9]  Simon Davies,et al.  Epidemiology: Study Design and Data Analysis (2nd ed.) , 2006 .

[10]  Colin W Shepard,et al.  Global epidemiology of hepatitis C virus infection. , 2005, The Lancet. Infectious diseases.

[11]  Josepa Ribes,et al.  Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.

[12]  Matthias Egger,et al.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.

[13]  F. Manguso,et al.  Increased IGF‐I : IGFBP‐3 ratio in patients with hepatocellular carcinoma , 2003, Clinical endocrinology.

[14]  T. Braulke,et al.  The Role of the IGF Axis in Hepatocarcinogenesis , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[15]  A. Juul.  Serum levels of insulin-like growth factor I and its binding proteins in health and disease. , 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[16]  M. Stampfer,et al.  Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. , 2002, Journal of the National Cancer Institute.

[17]  R. Baxter,et al.  Cellular actions of the insulin-like growth factor binding proteins. , 2002, Endocrine reviews.

[18]  C. Mantzoros,et al.  The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications , 2002, Oncology.

[19]  X. Shu,et al.  Insulin-like growth factors and breast cancer risk in Chinese women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[20]  D. Albanes,et al.  The Finnish Cancer Registry as Follow-Up Source of a Large Trial Cohort , 2002, Acta oncologica.

[21]  M. Stampfer,et al.  Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. , 2002, Journal of the National Cancer Institute.

[22]  J. Fraumeni,et al.  International trends and patterns of primary liver cancer , 2001, International journal of cancer.

[23]  C. Mantzoros,et al.  Insulin‐like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men , 2000, International journal of cancer.

[24]  M. Pollak.  Insulin-like growth factor physiology and cancer risk. , 2000, European journal of cancer.

[25]  A. Renehan,et al.  Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3 , 1999 .

[26]  Mark Woodward,et al.  Epidemiology: Study Design and Data Analysis , 1999 .

[27]  Stampfer,et al.  Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. , 1999, Journal of the National Cancer Institute.

[28]  M. Stampfer,et al.  Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. , 1998, Science.

[29]  J. French,et al.  Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. , 1997, Cancer research.

[30]  J. Concato,et al.  A simulation study of the number of events per variable in logistic regression analysis. , 1996, Journal of clinical epidemiology.

[31]  The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. , 1994, Annals of epidemiology.

[32]  M. Pinzani,et al.  Circulating growth hormone and insulin-like growth factor-I in nonalcoholic liver cirrhosis with or without superimposed hepatocarcinoma: evidence of an altered circadian rhythm. , 1993, The American journal of gastroenterology.

[33]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[34]  Chou Ck,et al.  Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia. , 1988 .

[35]  B. Chiang,et al.  Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia. , 1988, The Journal of laboratory and clinical medicine.

[36]  Z. Anusz.  [Statistics in epidemiology]. , 1974, Pielegniarka i polozna.